CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 56 enrolled
Drug / intervention
GI Sleeve Implantable weight loss device (EndoBarrier) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00469391
NCT00469391Phase 2Completed
CompareCT.gov

A Multi-Center, Pilot Efficacy Study of the GI Sleeve for Pre-Surgical Weight Loss

Morphic Medical Inc.·interventional·Posted May 4, 2007·Updated Feb 15, 2017

In Brief

A Phase 2 clinical trial evaluating GI Sleeve Implantable weight loss device (EndoBarrier) and Sham Procedure for Obesity. Completed, enrolled 56 participants across 4 sites.

Detailed Summary

The purpose of the study is to evaluate the safety and efficacy of the GI Sleeve in patients who require weight loss prior to their Bariatric surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 4, 2007
Enrollment StartJun 1, 2007
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 19.2 years ago

Interventions

GI Sleeve Implantable weight loss device (EndoBarrier)device

device for weight loss

Sham Procedureprocedure

Weight loss